364 related articles for article (PubMed ID: 37298621)
1. Liver Fibrosis Resolution: From Molecular Mechanisms to Therapeutic Opportunities.
Pei Q; Yi Q; Tang L
Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298621
[TBL] [Abstract][Full Text] [Related]
2. Collagenase-I decorated co-delivery micelles potentiate extracellular matrix degradation and hepatic stellate cell targeting for liver fibrosis therapy.
Zhou L; Liang Q; Li Y; Cao Y; Li J; Yang J; Liu J; Bi J; Liu Y
Acta Biomater; 2022 Oct; 152():235-254. PubMed ID: 36087869
[TBL] [Abstract][Full Text] [Related]
3. Targeting Hepatic Stellate Cell Death to Reverse Hepatic Fibrosis.
Zhang X; Zeng Y; Zhao L; Xu Q; Miao D; Yu F
Curr Drug Targets; 2023; 24(7):568-583. PubMed ID: 36999702
[TBL] [Abstract][Full Text] [Related]
4. Hepatic Stellate Cell-Macrophage Crosstalk in Liver Fibrosis and Carcinogenesis.
Matsuda M; Seki E
Semin Liver Dis; 2020 Aug; 40(3):307-320. PubMed ID: 32242330
[TBL] [Abstract][Full Text] [Related]
5. The herbal compound Songyou Yin (SYY) inhibits hepatocellular carcinoma growth and improves survival in models of chronic fibrosis via paracrine inhibition of activated hepatic stellate cells.
Bu Y; Jia QA; Ren ZG; Xue TC; Zhang QB; Zhang KZ; Zhang QB; You Y; Tian H; Qin LX; Tang ZY
Oncotarget; 2015 Nov; 6(37):40068-80. PubMed ID: 26517671
[TBL] [Abstract][Full Text] [Related]
6. Hepatic stellate cells and extracellular matrix in hepatocellular carcinoma: more complicated than ever.
Carloni V; Luong TV; Rombouts K
Liver Int; 2014 Jul; 34(6):834-43. PubMed ID: 24397349
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic potential of targeting regulatory mechanisms of hepatic stellate cell activation in liver fibrosis.
Baghaei K; Mazhari S; Tokhanbigli S; Parsamanesh G; Alavifard H; Schaafsma D; Ghavami S
Drug Discov Today; 2022 Apr; 27(4):1044-1061. PubMed ID: 34952225
[TBL] [Abstract][Full Text] [Related]
8. Recent Insight into the Role of Fibrosis in Nonalcoholic Steatohepatitis-Related Hepatocellular Carcinoma.
Sircana A; Paschetta E; Saba F; Molinaro F; Musso G
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30970564
[TBL] [Abstract][Full Text] [Related]
9. The Role of Fibrosis and Liver-Associated Fibroblasts in the Pathogenesis of Hepatocellular Carcinoma.
Baglieri J; Brenner DA; Kisseleva T
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30959975
[TBL] [Abstract][Full Text] [Related]
10. Activated Hepatic Stellate Cells in Hepatocellular Carcinoma: Their Role as a Potential Target for Future Therapies.
Ali E; Trailin A; Ambrozkiewicz F; Liška V; Hemminki K
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499616
[TBL] [Abstract][Full Text] [Related]
11. Hepatic Stellate Cell Modulates the Immune Microenvironment in the Progression of Hepatocellular Carcinoma.
Wang PW; Lin TY; Yang PM; Yeh CT; Pan TL
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142683
[TBL] [Abstract][Full Text] [Related]
12. A critical review on anti-fibrotic phytochemicals targeting activated hepatic stellate cells.
Vijayan N; Perumal MK
J Food Biochem; 2022 Dec; 46(12):e14438. PubMed ID: 36209494
[TBL] [Abstract][Full Text] [Related]
13. Newcastle disease virus represses the activation of human hepatic stellate cells and reverses the development of hepatic fibrosis in mice.
Li YL; Wu J; Wei D; Zhang DW; Feng H; Chen ZN; Bian H
Liver Int; 2009 Apr; 29(4):593-602. PubMed ID: 19192169
[TBL] [Abstract][Full Text] [Related]
14. PDGFRβ-targeted TRAIL specifically induces apoptosis of activated hepatic stellate cells and ameliorates liver fibrosis.
Li R; Li Z; Feng Y; Yang H; Shi Q; Tao Z; Cheng J; Lu X
Apoptosis; 2020 Feb; 25(1-2):105-119. PubMed ID: 31894448
[TBL] [Abstract][Full Text] [Related]
15. PHP14 regulates hepatic stellate cells migration in liver fibrosis via mediating TGF-β1 signaling to PI3Kγ/AKT/Rac1 pathway.
Xu A; Li Y; Zhao W; Hou F; Li X; Sun L; Chen W; Yang A; Wu S; Zhang B; Yao J; Wang H; Huang J
J Mol Med (Berl); 2018 Feb; 96(2):119-133. PubMed ID: 29098317
[TBL] [Abstract][Full Text] [Related]
16. Hepatic fibrosis: It is time to go with hepatic stellate cell-specific therapeutic targets.
Ezhilarasan D; Sokal E; Najimi M
Hepatobiliary Pancreat Dis Int; 2018 Jun; 17(3):192-197. PubMed ID: 29709350
[TBL] [Abstract][Full Text] [Related]
17. CCN1/Cyr61 enhances the function of hepatic stellate cells in promoting the progression of hepatocellular carcinoma.
Li ZQ; Wu WR; Zhao C; Zhao C; Zhang XL; Yang Z; Pan J; Si WK
Int J Mol Med; 2018 Mar; 41(3):1518-1528. PubMed ID: 29286082
[TBL] [Abstract][Full Text] [Related]
18. Succinate induces hepatic fibrogenesis by promoting activation, proliferation, and migration, and inhibiting apoptosis of hepatic stellate cells.
Park SY; Le CT; Sung KY; Choi DH; Cho EH
Biochem Biophys Res Commun; 2018 Feb; 496(2):673-678. PubMed ID: 29366478
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-10 induces senescence of activated hepatic stellate cells via STAT3-p53 pathway to attenuate liver fibrosis.
Huang YH; Chen MH; Guo QL; Chen ZX; Chen QD; Wang XZ
Cell Signal; 2020 Feb; 66():109445. PubMed ID: 31730896
[TBL] [Abstract][Full Text] [Related]
20. Wnt signaling in liver fibrosis: progress, challenges and potential directions.
Miao CG; Yang YY; He X; Huang C; Huang Y; Zhang L; Lv XW; Jin Y; Li J
Biochimie; 2013 Dec; 95(12):2326-35. PubMed ID: 24036368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
